GAY, Francesca Maria
GAY, Francesca Maria
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease
2016-01-01 Zamagni E.; Nanni C.; Gay F.; Pezzi A.; Patriarca F.; Bello M.; Rambaldi I.; Tacchetti P.; Hillengass J.; Gamberi B.; Pantani L.; Magarotto V.; Versari A.; Offidani M.; Zannetti B.; Carobolante F.; Balma M.; Musto P.; Rensi M.; Mancuso K.; Dimitrakopoulou-Strauss A.; Chauvie S.; Rocchi S.; Fard N.; Marzocchi G.; Storto G.; Ghedini P.; Palumbo A.; Fanti S.; Cavo M.
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde
2021-01-01 Musto, Pellegrino; Engelhardt, Monika; Caers, Jo; Bolli, Niccolo'; Kaiser, Martin; Van de Donk, Niels; Terpos, Evangelos; Broijl, Annemiek; De Larrea, Carlos Fernández; Gay, Francesca; Goldschmidt, Hartmut; Hajek, Roman; Vangsted, Annette Juul; Zamagni, Elena; Zweegman, Sonja; Cavo, Michele; Dimopoulos, Meletios; Einsele, Hermann; Ludwig, Heinz; Barosi, Giovanni; Boccadoro, Mario; Mateos, Maria-Victoria; Sonneveld, Pieter; Miguel, Jesus San
A Case-Matched Analysis Comparing Lenalidomide After Autologous or After Allogeneic Stem Cell Transplantation Demonstrates a Survival Advantage in Allografted Myeloma Patients
2012-01-01 Vittorio Montefusco; Francesco Spina; Elena Zamagni; Benedetto Bruno; Francesca Gay; Francesca Patriarca; Giorgia Saporiti; Monica Galli; Claudia Crippa; Lucia Farina; Anna Maria Cafro; Angelo Michele Carella; Paolo Corradini
A Multicenter, Open Label Study of Oral Lenalidomide and Prednisone (RP) Followed by Oral Lenalidomide Melphalan and Prednisone (MPR) and Oral Lenalidomide Maintenance In Newly Diagnosed Elderly Multiple Myeloma Patients
2010-01-01 Palumbo A; Falco P; Benevolo G; Rossi D; Carella AM; Guglielmelli T; Rocci A; De Paoli L; Grasso M; Mosca Siez ML; Piro E; Caltagirone S; Gay F; Cavallo F; Gaidano G; Boccadoro M
A new combination for advanced multiple myeloma.
2011-01-01 Palumbo A; Gay F.
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
2024-01-01 Sonneveld, Pieter; Dimopoulos, Meletios A.; Boccadoro, Mario; Quach, Hang; Ho, P. Joy; Beksac, Meral; Hulin, Cyrille; Antonioli, Elisabetta; Leleu, Xavier; Mangiacavalli, Silvia; Perrot, Aurore; Cavo, Michele; Belotti, Angelo; Broijl, Annemiek; Gay, Francesca; Mina, Roberto; van de Donk, Niels W.C.J.; Katodritou, Eirini; Schjesvold, Fredrik; Balari, Anna Sureda; Rosiñol, Laura; Delforge, Michel; Roeloffzen, Wilfried; Silzle, Tobias; Vangsted, Annette; Einsele, Hermann; Spencer, Andrew; Hajek, Roman; Jurczyszyn, Artur; Lonergan, Sarah; Ahmadi, Tahamtan; Liu, Yanfang; Wang, Jianping; Vieyra, Diego; van Brummelen, Emilie M.J.; Vanquickelberghe, Veronique; Sitthi-Amorn, Anna; de Boer, Carla J.; Carson, Robin; Rodriguez-Otero, Paula; Bladé, Joan; Moreau, Philippe
A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m2 (Mel200) Versus Melphalan 100 mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients.
2007-01-01 Palumbo A; Bringhen S; Petrucci MT; Falcone A; Liberati AM; Lauta VM; Grasso M; Montanaro M; Pisani F; Caravita T; Cangialosi C; Pregno P; Nozza A; Calabrese E; Gay F; Cavallo F; Omedè P; Musto P; Foà R; Boccadoro M
A rational approach to functional high-risk myeloma
2023-01-01 Gay, Francesca; Bertuglia, Giuseppe; Mina, Roberto
A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients
2013-01-01 Larocca, A; Bringhen, S; Evangelista, A; Offidani, M; Ballanti, S; Zaccaria, A; Pescosta, N; Montefusco, V; De Rosa, L; Carella, Am; Baldini, L; Aglietta, M; Vincelli, Id; Marasca, R; Pezzati, S; Tosi, P; Cocito, F; Grasso, M; Fioritoni, G; Pavone, V; Musto, P; Grammatico, S; Omede, P; Gay, F; Ciccone, G; Boccadoro, M; Palumbo, A
ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS
2010-01-01 F Gay; A Larocca; MT Petrucci; P Musto; AM Liberati; V Callea; R Ria; T Caravita; C Cangialosi; M Grasso; M Offidani; P Pregno; F Patriarca; M Galli; M Cavo; L Catalano; C Nozzoli; T Guglielmelli; R Zambello; F Pisani; V Montefusco; F Rossini; V De Stefano; B Lupo; F Di Raimondo; G Gaidano; M Boccadoro; A Palumbo
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells
2024-01-01 D'Agostino, Mattia; Rota-Scalabrini, Delia; Belotti, Angelo; Bertamini, Luca; Arigoni, Maddalena; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Pisani, Francesco; Pescosta, Norbert; Ruggeri, Marina; Rogers, Jennifer; Olivero, Martina; Garzia, Mariagrazia; Galieni, Piero; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Stefanoni, Paola; Zamagni, Elena; Bruno, Benedetto; Calogero, Raffaele Adolfo; Boccadoro, Mario; Musto, Pellegrino; Gay, Francesca
An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma
2024-01-01 de Jong, Madelon M E; Fokkema, Cathelijne; Papazian, Natalie; Czeti, Ágnes; Appelman, Marjolein K; Vermeulen, Michael; van Heusden, Teddie; Hoogenboezem, Remco M; van Beek, Gregory; Tahri, Sabrin; Sanders, Mathijs A; van de Woestijne, Pieter C; Gay, Francesca; Moreau, Philippe; Büttner-Herold, Maike; Bruns, Heiko; van Duin, Mark; Broijl, Annemiek; Sonneveld, Pieter; Cupedo, Tom
Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen?
2020-01-01 D'Agostino M.; Mina R.; Gay F.
Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates
2008-01-01 Montefusco V; Gay F; Spina F; Miceli R; Maniezzo M; Teresa Ambrosini M; Farina L; Piva S; Palumbo A; Boccadoro M; Corradini P.
Antibody-drug conjugates: when chemotherapy meets immuno-oncology
2021-01-01 Mina R.; Gay F.
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma
2022-01-01 Dhakal, Binod; Shah, Nina; Kansagra, Ankit; Kumar, Ambuj; Lonial, Sagar; Garfall, Alfred; Cowan, Andrew; Poudyal, Bishesh Sharma; Costello, Caitlin; Gay, Francesca; Cook, Gordon; Quach, Hang; Einsele, Herman; Schriber, Jeff; Hou, Jian; Costa, Luciano; Aljurf, Mahmoud; Chaudhry, Maria; Beksac, Meral; Prince, Miles; Mohty, Mohamad; Janakiram, Murali; Callander, Natalie; Biran, Noa; Malhotra, Pankaj; Otero, Paula Rodriguez; Moreau, Philippe; Abonour, Rafat; Iftikhar, Raheel; Silberman, Rebecca; Mailankody, Sham; Gregory, Tara; Lin, Yi; Carpenter, Paul; Hamadani, Mehdi; Usmani, Saad; Kumar, Shaji
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
2020-01-01 Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P.
Autologous transplant for myeloma: When the old meets the new
2017-01-01 Gay, Francesca*; Genuardi, Mariella; Boccadoro, Mario
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis
2017-01-01 Gay F, Oliva S, Petrucci MT, Montefusco V, Conticello C, Musto P, Catalano L, Evangelista A, Spada S, Campbell P, Ria R, Salvini M, Offidani M, Carella AM, Omedé P, Liberati AM, Troia R, Cafro AM, Malfitano A, Falcone AP, Caravita T, Patriarca F, Nagler A, Spencer A, Hajek R, Palumbo A, Boccadoro M.
Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
2014-01-01 Antonio Palumbo;Federica Cavallo;Francesca Gay;Francesco Di Raimondo;Dina Ben Yehuda;Maria Teresa Petrucci;Sara Pezzatti;Tommaso Caravita;Chiara Cerrato;Elena Ribakovsky;Mariella Genuardi;Anna Cafro;Magda Marcatti;Lucio Catalano;Massimo Offidani;Angelo Michele Carella;Elena Zamagni;Francesca Patriarca;Pellegrino Musto;Andrea Evangelista;Giovannino Ciccone;Paola Omed?;Claudia Crippa;Paolo Corradini;Arnon Nagler;Mario Boccadoro;Michele Cavo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease | 2016 | Zamagni E.; Nanni C.; Gay F.; Pezzi A.; Patriarca F.; Bello M.; Rambaldi I.; Tacchetti P.; Hillengass J.; Gamberi B.; Pantani L.; Magarotto V.; Versari A.; Offidani M.; Zannetti B.; Carobolante F.; Balma M.; Musto P.; Rensi M.; Mancuso K.; Dimitrakopoulou-Strauss A.; Chauvie S.; Rocchi S.; Fard N.; Marzocchi G.; Storto G.; Ghedini P.; Palumbo A.; Fanti S.; Cavo M. | |
| 2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde | 2021 | Musto, Pellegrino; Engelhardt, Monika; Caers, Jo; Bolli, Niccolo'; Kaiser, Martin; Van de Donk, Niels; Terpos, Evangelos; Broijl, Annemiek; De Larrea, Carlos Fernández; Gay, Francesca; Goldschmidt, Hartmut; Hajek, Roman; Vangsted, Annette Juul; Zamagni, Elena; Zweegman, Sonja; Cavo, Michele; Dimopoulos, Meletios; Einsele, Hermann; Ludwig, Heinz; Barosi, Giovanni; Boccadoro, Mario; Mateos, Maria-Victoria; Sonneveld, Pieter; Miguel, Jesus San | |
| A Case-Matched Analysis Comparing Lenalidomide After Autologous or After Allogeneic Stem Cell Transplantation Demonstrates a Survival Advantage in Allografted Myeloma Patients | 2012 | Vittorio Montefusco; Francesco Spina; Elena Zamagni; Benedetto Bruno; Francesca Gay; Francesca Patriarca; Giorgia Saporiti; Monica Galli; Claudia Crippa; Lucia Farina; Anna Maria Cafro; Angelo Michele Carella; Paolo Corradini | |
| A Multicenter, Open Label Study of Oral Lenalidomide and Prednisone (RP) Followed by Oral Lenalidomide Melphalan and Prednisone (MPR) and Oral Lenalidomide Maintenance In Newly Diagnosed Elderly Multiple Myeloma Patients | 2010 | Palumbo A; Falco P; Benevolo G; Rossi D; Carella AM; Guglielmelli T; Rocci A; De Paoli L; Grasso M; Mosca Siez ML; Piro E; Caltagirone S; Gay F; Cavallo F; Gaidano G; Boccadoro M | |
| A new combination for advanced multiple myeloma. | 2011 | Palumbo A; Gay F. | |
| A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma | 2024 | Sonneveld, Pieter; Dimopoulos, Meletios A.; Boccadoro, Mario; Quach, Hang; Ho, P. Joy; Beksac, Meral; Hulin, Cyrille; Antonioli, Elisabetta; Leleu, Xavier; Mangiacavalli, Silvia; Perrot, Aurore; Cavo, Michele; Belotti, Angelo; Broijl, Annemiek; Gay, Francesca; Mina, Roberto; van de Donk, Niels W.C.J.; Katodritou, Eirini; Schjesvold, Fredrik; Balari, Anna Sureda; Rosiñol, Laura; Delforge, Michel; Roeloffzen, Wilfried; Silzle, Tobias; Vangsted, Annette; Einsele, Hermann; Spencer, Andrew; Hajek, Roman; Jurczyszyn, Artur; Lonergan, Sarah; Ahmadi, Tahamtan; Liu, Yanfang; Wang, Jianping; Vieyra, Diego; van Brummelen, Emilie M.J.; Vanquickelberghe, Veronique; Sitthi-Amorn, Anna; de Boer, Carla J.; Carson, Robin; Rodriguez-Otero, Paula; Bladé, Joan; Moreau, Philippe | |
| A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m2 (Mel200) Versus Melphalan 100 mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients. | 2007 | Palumbo A; Bringhen S; Petrucci MT; Falcone A; Liberati AM; Lauta VM; Grasso M; Montanaro M; Pisani F; Caravita T; Cangialosi C; Pregno P; Nozza A; Calabrese E; Gay F; Cavallo F; Omedè P; Musto P; Foà R; Boccadoro M | |
| A rational approach to functional high-risk myeloma | 2023 | Gay, Francesca; Bertuglia, Giuseppe; Mina, Roberto | |
| A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients | 2013 | Larocca, A; Bringhen, S; Evangelista, A; Offidani, M; Ballanti, S; Zaccaria, A; Pescosta, N; Montefusco, V; De Rosa, L; Carella, Am; Baldini, L; Aglietta, M; Vincelli, Id; Marasca, R; Pezzati, S; Tosi, P; Cocito, F; Grasso, M; Fioritoni, G; Pavone, V; Musto, P; Grammatico, S; Omede, P; Gay, F; Ciccone, G; Boccadoro, M; Palumbo, A | |
| ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS | 2010 | F Gay; A Larocca; MT Petrucci; P Musto; AM Liberati; V Callea; R Ria; T Caravita; C Cangialosi; M Grasso; M Offidani; P Pregno; F Patriarca; M Galli; M Cavo; L Catalano; C Nozzoli; T Guglielmelli; R Zambello; F Pisani; V Montefusco; F Rossini; V De Stefano; B Lupo; F Di Raimondo; G Gaidano; M Boccadoro; A Palumbo | |
| Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells | 2024 | D'Agostino, Mattia; Rota-Scalabrini, Delia; Belotti, Angelo; Bertamini, Luca; Arigoni, Maddalena; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Pisani, Francesco; Pescosta, Norbert; Ruggeri, Marina; Rogers, Jennifer; Olivero, Martina; Garzia, Mariagrazia; Galieni, Piero; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Stefanoni, Paola; Zamagni, Elena; Bruno, Benedetto; Calogero, Raffaele Adolfo; Boccadoro, Mario; Musto, Pellegrino; Gay, Francesca | |
| An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma | 2024 | de Jong, Madelon M E; Fokkema, Cathelijne; Papazian, Natalie; Czeti, Ágnes; Appelman, Marjolein K; Vermeulen, Michael; van Heusden, Teddie; Hoogenboezem, Remco M; van Beek, Gregory; Tahri, Sabrin; Sanders, Mathijs A; van de Woestijne, Pieter C; Gay, Francesca; Moreau, Philippe; Büttner-Herold, Maike; Bruns, Heiko; van Duin, Mark; Broijl, Annemiek; Sonneveld, Pieter; Cupedo, Tom | |
| Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen? | 2020 | D'Agostino M.; Mina R.; Gay F. | |
| Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates | 2008 | Montefusco V; Gay F; Spina F; Miceli R; Maniezzo M; Teresa Ambrosini M; Farina L; Piva S; Palumbo A; Boccadoro M; Corradini P. | |
| Antibody-drug conjugates: when chemotherapy meets immuno-oncology | 2021 | Mina R.; Gay F. | |
| ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma | 2022 | Dhakal, Binod; Shah, Nina; Kansagra, Ankit; Kumar, Ambuj; Lonial, Sagar; Garfall, Alfred; Cowan, Andrew; Poudyal, Bishesh Sharma; Costello, Caitlin; Gay, Francesca; Cook, Gordon; Quach, Hang; Einsele, Herman; Schriber, Jeff; Hou, Jian; Costa, Luciano; Aljurf, Mahmoud; Chaudhry, Maria; Beksac, Meral; Prince, Miles; Mohty, Mohamad; Janakiram, Murali; Callander, Natalie; Biran, Noa; Malhotra, Pankaj; Otero, Paula Rodriguez; Moreau, Philippe; Abonour, Rafat; Iftikhar, Raheel; Silberman, Rebecca; Mailankody, Sham; Gregory, Tara; Lin, Yi; Carpenter, Paul; Hamadani, Mehdi; Usmani, Saad; Kumar, Shaji | |
| Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study | 2020 | Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P. | |
| Autologous transplant for myeloma: When the old meets the new | 2017 | Gay, Francesca*; Genuardi, Mariella; Boccadoro, Mario | |
| Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis | 2017 | Gay F, Oliva S, Petrucci MT, Montefusco V, Conticello C, Musto P, Catalano L, Evangelista A, Spada S, Campbell P, Ria R, Salvini M, Offidani M, Carella AM, Omedé P, Liberati AM, Troia R, Cafro AM, Malfitano A, Falcone AP, Caravita T, Patriarca F, Nagler A, Spencer A, Hajek R, Palumbo A, Boccadoro M. | |
| Autologous Transplantation and Maintenance Therapy in Multiple Myeloma | 2014 | Antonio Palumbo;Federica Cavallo;Francesca Gay;Francesco Di Raimondo;Dina Ben Yehuda;Maria Teresa Petrucci;Sara Pezzatti;Tommaso Caravita;Chiara Cerrato;Elena Ribakovsky;Mariella Genuardi;Anna Cafro;Magda Marcatti;Lucio Catalano;Massimo Offidani;Angelo Michele Carella;Elena Zamagni;Francesca Patriarca;Pellegrino Musto;Andrea Evangelista;Giovannino Ciccone;Paola Omed?;Claudia Crippa;Paolo Corradini;Arnon Nagler;Mario Boccadoro;Michele Cavo |